Category:Timeline Stories

Back to Trailblazers Hub


The Action Statement on Heart Failure

A call to action outlining clear policy recommendations for European institutions to address the growing burden of heart failure.

Read More
Heart failure and COVID‑19

People with pre-existing cardiovascular disease, including heart failure, have an increased risk of becoming severely ill from COVID-19.

Read More
Spotlight series

Two new Spotlight reports examine worsening heart failure and the relationship between cancer treatment and heart failure were published.

Read More
Heart failure policy and practice in Europe

Heart failure policy and practice in Europe aims to support advocates with clear outline of policy issues and best practice in heart failure across 11 European countries.

Read More
HF Pledge

The HF pledge campaign called on candidates in the 2019 European Parliament elections to pledge their support to improving the lives of people with heart failure.

Read More
The Heart Failure Policy Toolkit

The Heart Failure Policy Toolkit is a policy resource aiming to expose existing gaps in heart failure care and offer integrated, sustainable solutions.

Read More
Written Declaration on heart failure

Written Declaration 110/2016 on Heart Failure was one of the first official policy opportunities in the European Union to build a clear consensus that heart failure is a policy priority.

Read More
State of play summaries

The HFPN produced two brief summaries on the state of play for two fundamental elements of heart failure care: diagnosis and clinical management.

Read More
The handbook of multidisciplinary and integrated heart failure care

The handbook is designed to help solve problems and drive change that will make a meaningful difference to care for people living with heart failure.

Read More
Spotlight series

The Spotlight series features evidence-based reports on topics at the forefront of debates and challenges in the future of heart failure care.

Read More
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Roche Diagnostics, Bayer and Netherlands Heart Institute. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership.